Skip to main content
Premium Trial:

Request an Annual Quote

CeMines Opens New Division in Estonia

NEW YORK, Dec. 3 (GenomeWeb News) - CeMines has created a new operating division in Estonia called CeMines International, which will become a wholly owned subsidiary of CeMines, the company said today.


In Estonia, CeMines will "expand [its] research-and-development initiatives, establish a regulatory-affairs presence in the European Union and accelerate commercialization of new methods and technology," according to CEO Roger Attick.


"A comprehensive international business strategy is central to long-term competitive advantages," Attick added. CeMines will also leverage its presence in Europeto cultivate new research partnerships and distribution channels."


CeMines, based in Golden, Colo., is developing its molecular fingerprinting technologies for early-stage diagnostics and therapeutics.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more